# FDA recall D-0723-2021

> **PAI Holdings, LLC. dba Pharmaceutical Associates Inc** · Class II · drug recall initiated 2021-07-29.

## Product

Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY,  Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0670-16

## Reason for recall

Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.

## Distribution

Distributed Nationwide in the USA

## Key facts

- **Recall number:** D-0723-2021
- **Recalling firm:** PAI Holdings, LLC. dba Pharmaceutical Associates Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-07-29
- **Report date:** 2021-08-18
- **Termination date:** 2022-12-02

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Greenville, SC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0723-2021

## Citation

> AI Analytics. FDA recall D-0723-2021. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0723-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*